| Class 3 Device Recall Advance Microdraw Blood Glucose Monitoring System | |
Date Initiated by Firm | October 18, 2007 |
Date Posted | December 13, 2007 |
Recall Status1 |
Terminated 3 on March 02, 2008 |
Recall Number | Z-0458-2008 |
Recall Event ID |
45483 |
Product Classification |
Blood Glucose Monitoring System - Product Code CGA
|
Product | Hypoguard Advance Micro-draw Blood Glucose Monitoring System, Product Number : 411100, For In Vitro Diagnostic Use, Manufactured for ARKRAY USA, Inc., Minneapolis, MN 55439 USA. (Package Contents -Advance Micro-draw Blood Glucose Meter, 10 test Strips, Codeing chip and Control Solution (3mL), Lancing device, 10 Lancets, 3V Lithium Battery, Logbook, User Instruction Manual, Quick Reference Guide) |
Code Information |
Part Number 411100, Lot Number: 09177A |
Recalling Firm/ Manufacturer |
ARKRAY USA INC. 5182 W 76th St Minneapolis MN 55439-2900
|
For Additional Information Contact | 952-646-3168 |
Manufacturer Reason for Recall | Mis-labeled/coded strips : Meter kits from this lot contain mislabeled 10-count test strip vials. The code number printed on the Advance Micro-draw 10-count test strip bottle is incorrect. The code number on the vial is 867 when it should be 687. The 687-labeled code chip contains the correct calibration information for the "867" test strips, so the meter will function properly and give accurat |
FDA Determined Cause 2 | Process control |
Action | Distributors were sent a letter on 10/18/07 asking that product be quarantined. On 10/26/07, an Urgent Voluntary Medical Device Recall letter was sent asking that they return affected product and contact their customers to the retail level. |
Quantity in Commerce | 2,005 Kits |
Distribution | Nationwide: USA including states of CA, MI, MO, MS, NE, OH and TX. |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|